ITGAM and chronic obstructive pulmonary disease: In this study, CD11b+ populations, Mo-AM (16.0%), IM1 (8.2%), and IM3 (7.1%), decreased in size at 12 weeks of CS (Figure S2C), corresponding to clinical observations of expanded small macrophages in COPD lung sections (7).